APO RESEARCH · REPORT
Ergothioneine (EGT)
Ergothioneine is a naturally occurring amino acid and is a thiourea derivative of histidine, containing a sulfur atom on the imidazole ring. This compound is made in relatively few organisms, notably Actinobacteria, Cyanobacteria, and certain fungi.
Product & engineering
Understand the product.
Ergothioneine is a naturally occurring amino acid and is a thiourea derivative of histidine, containing a sulfur atom on the imidazole ring. This compound is made in relatively few organisms, notably Actinobacteria, Cyanobacteria, and certain fungi.
Selected research
Market Outlook & Growth Opportunities
Global Ergothioneine (EGT) Market Outlook and Growth Opportunities 2026
Market perspective
Ergothioneine is a naturally occurring amino acid and is a thiourea derivative of histidine, containing a sulfur atom on the imidazole ring. This compound is made in relatively few organisms, notably Actinobacteria, Cyanobacteria, and certain fungi.
Global key players of Ergothioneine (EGT) include Tetrahedron, Mironova Labs, Blue California, Aktin Chemicals,Inc. and Sobeo Biotech, etc. Top two players occupy for a share about 87%. North America is the largest market, with a share about 47%, followed by China and Europe. In terms of product, Chemical synthesis Method is the largest segment, with a share over 87%. In terms of application, Medical Industry is the largest market, with a share over 50%.
This report provides an overview of the global Ergothioneine (EGT) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Ergothioneine (EGT) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ergothioneine (EGT) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ergothioneine (EGT) market size, projected growth trends, production technologies, key applications, and end-use industries.
Ergothioneine (EGT) Segment by Company
Mironova Labs
Tetrahedron
Blue California
Aktin Chemicals,Inc.
Sobeo Biotech
Bloomage Bioactive
Sinonocy
Taizhou Tianhong Biochemistry Technology Co., Ltd.
Ergothioneine (EGT) Segment by Type
Chemical synthesis Method
Fermentation Method
Other
Ergothioneine (EGT) Segment by Application
Medical Industry
Food Industry
Cosmetics Industry
Ergothioneine (EGT) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Ergothioneine (EGT) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Ergothioneine (EGT) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Ergothioneine (EGT) significant trends, drivers, influence factors in global and regions.
6. To analyze Ergothioneine (EGT) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ergothioneine (EGT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ergothioneine (EGT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ergothioneine (EGT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ergothioneine (EGT) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ergothioneine (EGT) industry.
Chapter 3: Detailed analysis of Ergothioneine (EGT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Ergothioneine (EGT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Ergothioneine (EGT) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical synthesis Method
- Fermentation Method
- Other
Applications
- Medical Industry
- Food Industry
- Cosmetics Industry
Companies covered
- Mironova Labs
- Tetrahedron
- Blue California
- Aktin Chemicals,Inc.
- Sobeo Biotech
- Bloomage Bioactive
- Sinonocy
- Taizhou Tianhong Biochemistry Technology Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Ergothioneine (EGT) Sales Value (2021-2032)
- 1.2.2 Global Ergothioneine (EGT) Sales Volume (2021-2032)
- 1.2.3 Global Ergothioneine (EGT) Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Ergothioneine (EGT) Market Dynamics
- 2.1 Ergothioneine (EGT) Industry Trends
- 2.2 Ergothioneine (EGT) Industry Drivers
- 2.3 Ergothioneine (EGT) Industry Opportunities and Challenges
- 2.4 Ergothioneine (EGT) Industry Restraints
3 Ergothioneine (EGT) Market by Company
- 3.1 Global Ergothioneine (EGT) Company Revenue Ranking in 2025
- 3.2 Global Ergothioneine (EGT) Revenue by Company (2021-2026)
- 3.3 Global Ergothioneine (EGT) Sales Volume by Company (2021-2026)
- 3.4 Global Ergothioneine (EGT) Average Price by Company (2021-2026)
- 3.5 Global Ergothioneine (EGT) Company Ranking (2024-2026)
- 3.6 Global Ergothioneine (EGT) Company Manufacturing Base and Headquarters
- 3.7 Global Ergothioneine (EGT) Company Product Type and Application
- 3.8 Global Ergothioneine (EGT) Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Ergothioneine (EGT) Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Ergothioneine (EGT) Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Ergothioneine (EGT) Market by Type
- 4.1 Ergothioneine (EGT) Type Introduction
- 4.1.1 Chemical synthesis Method
- 4.1.2 Fermentation Method
- 4.1.3 Other
- 4.2 Global Ergothioneine (EGT) Sales Volume by Type
- 4.2.1 Global Ergothioneine (EGT) Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ergothioneine (EGT) Sales Volume by Type (2021-2032)
- 4.2.3 Global Ergothioneine (EGT) Sales Volume Share by Type (2021-2032)
- 4.3 Global Ergothioneine (EGT) Sales Value by Type
- 4.3.1 Global Ergothioneine (EGT) Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ergothioneine (EGT) Sales Value by Type (2021-2032)
- 4.3.3 Global Ergothioneine (EGT) Sales Value Share by Type (2021-2032)
5 Ergothioneine (EGT) Market by Application
- 5.1 Ergothioneine (EGT) Application Introduction
- 5.1.1 Medical Industry
- 5.1.2 Food Industry
- 5.1.3 Cosmetics Industry
- 5.2 Global Ergothioneine (EGT) Sales Volume by Application
- 5.2.1 Global Ergothioneine (EGT) Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ergothioneine (EGT) Sales Volume by Application (2021-2032)
- 5.2.3 Global Ergothioneine (EGT) Sales Volume Share by Application (2021-2032)
- 5.3 Global Ergothioneine (EGT) Sales Value by Application
- 5.3.1 Global Ergothioneine (EGT) Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ergothioneine (EGT) Sales Value by Application (2021-2032)
- 5.3.3 Global Ergothioneine (EGT) Sales Value Share by Application (2021-2032)
6 Ergothioneine (EGT) Regional Sales and Value Analysis
- 6.1 Global Ergothioneine (EGT) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ergothioneine (EGT) Sales by Region (2021-2032)
- 6.2.1 Global Ergothioneine (EGT) Sales by Region: 2021-2026
- 6.2.2 Global Ergothioneine (EGT) Sales by Region (2027-2032)
- 6.3 Global Ergothioneine (EGT) Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Ergothioneine (EGT) Sales Value by Region (2021-2032)
- 6.4.1 Global Ergothioneine (EGT) Sales Value by Region: 2021-2026
- 6.4.2 Global Ergothioneine (EGT) Sales Value by Region (2027-2032)
- 6.5 Global Ergothioneine (EGT) Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Ergothioneine (EGT) Sales Value (2021-2032)
- 6.6.2 North America Ergothioneine (EGT) Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Ergothioneine (EGT) Sales Value (2021-2032)
- 6.7.2 Europe Ergothioneine (EGT) Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Ergothioneine (EGT) Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Ergothioneine (EGT) Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Ergothioneine (EGT) Sales Value (2021-2032)
- 6.9.2 South America Ergothioneine (EGT) Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Ergothioneine (EGT) Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Ergothioneine (EGT) Sales Value Share by Country, 2025 VS 2032
7 Ergothioneine (EGT) Country-level Sales and Value Analysis
- 7.1 Global Ergothioneine (EGT) Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Ergothioneine (EGT) Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Ergothioneine (EGT) Sales by Country (2021-2032)
- 7.3.1 Global Ergothioneine (EGT) Sales by Country (2021-2026)
- 7.3.2 Global Ergothioneine (EGT) Sales by Country (2027-2032)
- 7.4 Global Ergothioneine (EGT) Sales Value by Country (2021-2032)
- 7.4.1 Global Ergothioneine (EGT) Sales Value by Country (2021-2026)
- 7.4.2 Global Ergothioneine (EGT) Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.9.2 France Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.16.2 China Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.19.2 India Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Ergothioneine (EGT) Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Ergothioneine (EGT) Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Ergothioneine (EGT) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Mironova Labs
- 8.1.1 Mironova Labs Company Information
- 8.1.2 Mironova Labs Business Overview
- 8.1.3 Mironova Labs Ergothioneine (EGT) Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Mironova Labs Ergothioneine (EGT) Product Portfolio
- 8.1.5 Mironova Labs Recent Developments
- 8.2 Tetrahedron
- 8.2.1 Tetrahedron Company Information
- 8.2.2 Tetrahedron Business Overview
- 8.2.3 Tetrahedron Ergothioneine (EGT) Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Tetrahedron Ergothioneine (EGT) Product Portfolio
- 8.2.5 Tetrahedron Recent Developments
- 8.3 Blue California
- 8.3.1 Blue California Company Information
- 8.3.2 Blue California Business Overview
- 8.3.3 Blue California Ergothioneine (EGT) Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Blue California Ergothioneine (EGT) Product Portfolio
- 8.3.5 Blue California Recent Developments
- 8.4 Aktin Chemicals,Inc.
- 8.4.1 Aktin Chemicals,Inc. Company Information
- 8.4.2 Aktin Chemicals,Inc. Business Overview
- 8.4.3 Aktin Chemicals,Inc. Ergothioneine (EGT) Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Aktin Chemicals,Inc. Ergothioneine (EGT) Product Portfolio
- 8.4.5 Aktin Chemicals,Inc. Recent Developments
- 8.5 Sobeo Biotech
- 8.5.1 Sobeo Biotech Company Information
- 8.5.2 Sobeo Biotech Business Overview
- 8.5.3 Sobeo Biotech Ergothioneine (EGT) Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Sobeo Biotech Ergothioneine (EGT) Product Portfolio
- 8.5.5 Sobeo Biotech Recent Developments
- 8.6 Bloomage Bioactive
- 8.6.1 Bloomage Bioactive Company Information
- 8.6.2 Bloomage Bioactive Business Overview
- 8.6.3 Bloomage Bioactive Ergothioneine (EGT) Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Bloomage Bioactive Ergothioneine (EGT) Product Portfolio
- 8.6.5 Bloomage Bioactive Recent Developments
- 8.7 Sinonocy
- 8.7.1 Sinonocy Company Information
- 8.7.2 Sinonocy Business Overview
- 8.7.3 Sinonocy Ergothioneine (EGT) Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Sinonocy Ergothioneine (EGT) Product Portfolio
- 8.7.5 Sinonocy Recent Developments
- 8.8 Taizhou Tianhong Biochemistry Technology Co., Ltd.
- 8.8.1 Taizhou Tianhong Biochemistry Technology Co., Ltd. Company Information
- 8.8.2 Taizhou Tianhong Biochemistry Technology Co., Ltd. Business Overview
- 8.8.3 Taizhou Tianhong Biochemistry Technology Co., Ltd. Ergothioneine (EGT) Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Taizhou Tianhong Biochemistry Technology Co., Ltd. Ergothioneine (EGT) Product Portfolio
- 8.8.5 Taizhou Tianhong Biochemistry Technology Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ergothioneine (EGT) Value Chain Analysis
- 9.1.1 Ergothioneine (EGT) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ergothioneine (EGT) Sales Mode & Process
- 9.2 Ergothioneine (EGT) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ergothioneine (EGT) Distributors
- 9.2.3 Ergothioneine (EGT) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst